Pegloticase Plus Methotrexate Gets Priority Review for Uncontrolled Gout
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for the use of pegloticase injection plus methotrexate for the treatment of uncontrolled gout. Pegloticase, a PEGylated uric…